heally tirzepatide FDA grants fast track designation to tirzepatide, Eli Lilly's new type 2 diabetes drug, for treating obesity Eli Lilly weight loss drug

If your nausea spikes dramatically one week with no dose change, check your conversion math before assuming the medication is causing problems

Evaluation method Results were assessed using three methods: (1) SALT (Severity of Alopecia Tool) scoring, (2) blinded dermatologist evaluation of before/after photographs, and (3) AI-assisted assessment using ChatGPT

Glucagon-like peptide-1 receptor agonists and kidney outcomes

The levels of the oxidative stress indicators MDA and SOD suggested an enhanced oxidation state in the control group, while the opposite trends were observed in the GSH-treated group (Fig

The observed heterogeneity in efficacy reflects complex interactions across multiple levels: host factors (genetic background, baseline microbiota, immune status)

Cardiovascular risk If you have established cardiovascular disease with type 2 diabetes, it is suggested to talk to your healthcare professional before switching to Zepbound